Analystreport

Fate Therapeutics (NASDAQ:FATE) had its "hold" rating reaffirmed by analysts at Needham & Company LLC.

Fate Therapeutics, Inc.  (FATE) 
Last fate therapeutics, inc. earnings: 3/2 04:01 pm Check Earnings Report
US:NASDAQ Investor Relations: ir.fatetherapeutics.com/investor-relations